Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit
Recently more and more cases of viral community-acquired pneumonia have been recorded. Laboratory markers (C-reactive protein, procalcitonin) can help diagnose this disease and determine its prognosis. When choosing an antimicrobial drug, data on antibiotic resistance, the presence of concomitant di...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/268 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839591504182509568 |
|---|---|
| author | Yu. V. Evsutina |
| author_facet | Yu. V. Evsutina |
| author_sort | Yu. V. Evsutina |
| collection | DOAJ |
| description | Recently more and more cases of viral community-acquired pneumonia have been recorded. Laboratory markers (C-reactive protein, procalcitonin) can help diagnose this disease and determine its prognosis. When choosing an antimicrobial drug, data on antibiotic resistance, the presence of concomitant diseases, previous antibiotic therapy should be taken into consideration. An effective measure for the prevention of community-acquired pneumonia is vaccination against pneumococcus and influenza. |
| format | Article |
| id | doaj-art-70193d1b194b44a0a8d0c8cc50d3e6a5 |
| institution | Matheson Library |
| issn | 1560-5175 2687-1181 |
| language | Russian |
| publishDate | 2021-06-01 |
| publisher | Open Systems Publication |
| record_format | Article |
| series | Лечащий Врач |
| spelling | doaj-art-70193d1b194b44a0a8d0c8cc50d3e6a52025-08-03T13:02:50ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812021-06-01011565910.26295/OS.2019.89.41.013267Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology SummitYu. V. Evsutina0ФГБУ НМИЦПМ Минздрава РоссииRecently more and more cases of viral community-acquired pneumonia have been recorded. Laboratory markers (C-reactive protein, procalcitonin) can help diagnose this disease and determine its prognosis. When choosing an antimicrobial drug, data on antibiotic resistance, the presence of concomitant diseases, previous antibiotic therapy should be taken into consideration. An effective measure for the prevention of community-acquired pneumonia is vaccination against pneumococcus and influenza.https://journal.lvrach.ru/jour/article/view/268community-acquired pneumoniaantibiotic therapyantibiotic resistancepneumococcus |
| spellingShingle | Yu. V. Evsutina Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit Лечащий Врач community-acquired pneumonia antibiotic therapy antibiotic resistance pneumococcus |
| title | Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit |
| title_full | Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit |
| title_fullStr | Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit |
| title_full_unstemmed | Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit |
| title_short | Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit |
| title_sort | community acquired pneumonia briefly about the main what is important to know to the physician based on the materials of the russian national congress man and drug and the iii pulmonology summit |
| topic | community-acquired pneumonia antibiotic therapy antibiotic resistance pneumococcus |
| url | https://journal.lvrach.ru/jour/article/view/268 |
| work_keys_str_mv | AT yuvevsutina communityacquiredpneumoniabrieflyaboutthemainwhatisimportanttoknowtothephysicianbasedonthematerialsoftherussiannationalcongressmananddrugandtheiiipulmonologysummit |